Dauricinoline is an orally active NF-κB inhibitor that can significantly inhibit NF-κB activation induced by TNF-α. Dauricinoline exhibits certain anti-inflammatory activity and can be used in the research of inflammatory diseases such as lung inflammation.
Products | Products > Signaling Pathways > NF-κB | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > NF-κB
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.
日本语
한국어
Français
Deutsch
España
Türkiye